edoc

Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients : lack of new sensitization to nontreated insect venom

Spoerl, D. and Bircher, A. J. and Scherer, K.. (2011) Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients : lack of new sensitization to nontreated insect venom. Journal of investigational allergology & clinical immunology, Vol. 21, H. 1. pp. 22-27.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6004899

Downloads: Statistics Overview

Abstract

Venom immunotherapy (VIT) has proven to be efficacious in reducing the severity of anaphylactic reactions following field stings in patients with Hymenoptera venom allergy. Due to sequence homologies in the allergens used in Hymenoptera vaccines, there is concern that immunotherapy could lead to sensitization to allergens to which patients were not previously sensitized. The relevance of such an undesired phenomenon is unclear.
Faculties and Departments:03 Faculty of Medicine > Bereich Spezialf├Ącher (Klinik) > Dermatologie USB > Dermatologie (Bircher)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Spezialf├Ącher (Klinik) > Dermatologie USB > Dermatologie (Bircher)
UniBasel Contributors:Bircher, Andreas J.
Item Type:Article, refereed
Article Subtype:Research Article
Bibsysno:Link to catalogue
Publisher:Esmon Publicidad
Note:Publication type according to Uni Basel Research Database: Journal article
Last Modified:16 Aug 2013 07:35
Deposited On:16 Aug 2013 07:33

Repository Staff Only: item control page